Skip to main content
. 2018 Jul 11;58(2):61–67. doi: 10.3960/jslrt.18014

Fig. 2.

Fig. 2

(a-c) Slide showing (a) CD138(+), (b) kappa-ISH (+), and (c) lambda-ISH (-) myeloma cells. (d-f) Slide showing the abnormal expression of (d) CD56, (e) cyclin D1, and (f) CD117 in myeloma cells. (a, d-f) Immunohistochemical staining. (b, c) ISH.